VTYX Archived Articles
Ventyx Biosciences (NASDAQ:VTYX): A Clinical-Stage Biopharma Innovator Advancing Oral Therapies for Inflammatory Diseases
Published on March 14, 2025
Ventyx Biosciences (NASDAQ:VTYX): A Rising Powerhouse in the Immunology Space
Published on November 17, 2024
Ventyx Biosciences, Inc. (VTYX): A Promising Pipeline of Novel Therapies Targeting Inflammatory Diseases
Published on September 24, 2024